Anti-Human APP Recombinant Antibody(Crenezumab)

Name: Anti-Human APP Recombinant Antibody(Crenezumab)
Brand: KMD Bioscience
SKU: YR1256

YR1256

科研级 Crenezumab ( 克瑞组单抗 ), Anti-APP Recombinant Antibody, Research Grade Crenezumab

DATASHEET MSDS

Product Description

Alias	科研级 Crenezumab ( 克瑞组单抗 ), Anti-APP Recombinant Antibody, Research Grade Crenezumab
Catalog Number	YR1256
Molecular Name	Crenezumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Crenezumab is a fully humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid-β peptides.
CAS Number	1095207-05-8
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	APP[Homo sapiens]

Login